<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rpmj</journal-id><journal-title-group><journal-title xml:lang="ru">Research'n Practical Medicine Journal</journal-title><trans-title-group xml:lang="en"><trans-title>Research and Practical Medicine Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2410-1893</issn><publisher><publisher-name>"QUASAR", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17709/2410-1893-2023-10-2-4</article-id><article-id custom-type="edn" pub-id-type="custom">TDFHIL</article-id><article-id custom-type="elpub" pub-id-type="custom">rpmj-919</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи. Онкология, лучевая терапия</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Articles. Оncology</subject></subj-group></article-categories><title-group><article-title>Морфометрические показатели тазовых лимфатических узлов при экспериментальном метастатическом раке предстательной железы</article-title><trans-title-group xml:lang="en"><trans-title>Morphometric parameters of pelvic lymph nodes in experimental metastatic prostate cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2846-1944</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асташов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Astashov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Асташов Вадим Васильевич – д.м.н., профессор, профессор кафедры анатомии человека, ФГАОУ ВО «Российский университет дружбы народов», Москва, Российская Федерация</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0003-2846-1944" ext-link-type="uri">https://orcid.org/0000-0003-2846-1944</ext-link>, SPIN: 2568-3442, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=81021" ext-link-type="uri">81021</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Vadim V. Astashov – Dr. Sc. (Medicine), Professor, Professor of the Department of Human Anatomy, Medical Institute, RUDN University, Moscow, Moscow, Russian Federation</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0003-2846-1944" ext-link-type="uri">https://orcid.org/0000-0003-2846-1944</ext-link>, SPIN: 2568-3442, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=81021" ext-link-type="uri">81021</ext-link></p><p> </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4468-3670</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кульченко</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulchenko</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Кульченко Нина Геннадьевна – к.м.н., врач-уролог, врач ультразвуковой диагностики, доцент кафедры анатомии человека Медицинского института ФГАОУ ВО «Российский университет дружбы народов», г. Москва, Российская Федерация; ведущий научный сотрудник Научно-образовательного ресурсного центра инновационных технологий иммунофенотипирования, цифрового пространственного профилирования и ультраструктурного анализа ФГАОУ ВО «Российский университет дружбы народов», г. Москва, Российская Федерация</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-4468-3670" ext-link-type="uri">https://orcid.org/0000-0002-4468-3670</ext-link>, SPIN: 1899-7871, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=543055" ext-link-type="uri">543055</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Nina G. Kulchenko – Cand. Sci. (Medicine), Urologist, Ultrasound Diagnostics Doctor, Associate Professor at the Department of Human Anatomy, Medical Faculty, RUDN University, Moscow, Moscow, Russian Federation; Senior Researcher of the Scientific and Educational Resource Center for Innovative Technologies of Immunophenotyping, Digital Spatial Profiling and Ultrastructural Analysis, RUDN University</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-4468-3670" ext-link-type="uri">https://orcid.org/0000-0002-4468-3670</ext-link>, SPIN: 1899-7871, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=543055" ext-link-type="uri">543055</ext-link></p><p> </p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет дружбы народов</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples' Friendship University of Russia (RUDN University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>12</day><month>06</month><year>2023</year></pub-date><volume>10</volume><issue>2</issue><fpage>40</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Асташов В.В., Кульченко Н.Г., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Асташов В.В., Кульченко Н.Г.</copyright-holder><copyright-holder xml:lang="en">Astashov V.V., Kulchenko N.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.rpmj.ru/rpmj/article/view/919">https://www.rpmj.ru/rpmj/article/view/919</self-uri><abstract><sec><title>Цель</title><p>Цель. Выявление структурно‑функциональных изменений в тазовых лимфатических узлах при экспериментальном метастатическом раке предстательной железы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В исследование было включено 30 мышей‑ самцов в возрасте 3 мес. Все животные (n = 30) были разделены на 2 группы. В первую группу (основная, n = 20) были включены мыши, которым была создана модель метастатического рака предстательной железы путем перевивки опухоли Эрлиха в паренхиму предстательной железы. Эти животные были дополнительно разделены на две равные подгруппы: 1а (n = 10) – мыши были выведены из эксперимента на 7‑е сутки; 1б (n = 10) – мыши были выведены из эксперимента на 18‑е сутки. Во вторую группу (n = 10) были включены мыши, с которыми манипуляции не производились, они составили контрольную группу. После окончания эксперимента с помощью световой микроскопии проводился морфологический анализ предстательной железы и регионарных (тазовых) лимфатических узлов у мышей обеих групп. Статистическую обработку результатов проводили с использованием пакета программ Statistica 8.0. Различия считали статистически значимыми при р &lt; 0,05.</p></sec><sec><title>Результаты</title><p>Результаты. При сравнении в контрольной группой у мышей группы 1а и 1б паренхима предстательной железы была практически полностью замещена атипичными клетками, что демонстрирует наличие неопластических процессов в предстательной железе. У мышей группы 1а количество тазовых лимфоузлов было в 1,9 раз больше, а у животных 1б группы этот показатель был выше в 2,7 раз по сравнению с второй группой (p &lt; 0,01). У животных первой группы доля тучных клеток в тазовых лимфатических узлах увеличилась на 121 % по сравнению с контрольной группой (p &lt; 0,01). При этом мы выявили прямую зависимость тучных клеток с количеством опухолевых клеток и иммунобластов в мозговых синусах, что свидетельствует об участии тканевых базофилов в метастазировании опухоли. Так же мы зафиксировали достоверное увеличение площади мозговых синусов регионарных лимфатических узлов у животных групп 1а на 12,4 % (p &lt; 0,05) и 1б на 20,2 % (p &lt; 0,01) на фоне увеличения количества тучных клеток в этой зоне по сравнению с контрольной группой, что указывает на возможное участие тучных клеток в лимфангиогенезе.</p></sec><sec><title>Заключение</title><p>Заключение. Тучные клетки потенциально могут играть определенную роль в развитии злокачественных новообразований предстательной железы. Количество тучных клеток увеличивается в тазовых лимфоузлах у животных с созданной моделью метастатического рака предстательной железы. Полученная прямая зависимость увеличения количества тучных клеток и рост числа опухолевых клеток с иммунобластами позволяет предположить, участие тканевых базофилов в распространении метастазов. Можно считать, что инфильтрация тучными клетками лимфатических узлов может коррелировать с плохим прогнозом развития рака предстательной железы, так как эти гранулоциты способствуют метастазированию опухоли.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>The study purpose</title><p>The study purpose. Identification of structural and functional changes in pelvic lymph nodes in experimental metastatic prostate cancer.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The study included 30 male mice aged 3 months. All animals (n = 30) were divided into 2 groups. The first group (the main one, n = 20) included mice that had a model of metastatic prostate cancer created by transplanting an Ehrlich tumor into the prostate parenchyma. These animals were further divided into two equal subgroups: 1a (n = 10) – mice were withdrawn from the experiment on day 7; 1b (n = 10) – mice were withdrawn from the experiment on day 18. The second group (n = 10) included mice that were not manipulated, they made up the control group. After the end of the experiment, morphological analysis of the prostate gland and regional (pelvic) lymph nodes in mice of both groups was performed using light microscopy. Statistical processing of the results was carried out using the Statistica 8.0 software package. The differences were considered statistically significant at p &lt; 0.05.</p></sec><sec><title>Results</title><p>Results. When compared to the control group the mice of groups 1a and 1b, the prostate parenchyma was almost completely replaced by atypical cells, which demonstrates the presence of neoplastic processes in the prostate gland. In group 1a mice, the number of pelvic lymph nodes was 1.9 times as large, and in group 1b animals, this indicator was 2.7 times higher compared to the second group (p &lt; 0.01). In animals of the first group, the proportion of mast cells in the pelvic lymph nodes increased by 121 % compared to the control group (p &lt; 0.01). At the same time, we revealed a direct relationship of mast cells with the number of tumor cells and immunoblasts in the medullar sinuses, which indicates the participation of tissue basophils in tumor metastasis. We also recorded a significant increase in the area of the medullar sinuses of regional lymph nodes in animals of groups 1a by 12.4 % (p &lt; 0.05) and 1b by 20.2 % (p &lt; 0.01) against the background of an increase in the number of mast cells in this zone compared to the control group, which indicates the possible participation of mast cells in lymphangiogenesis.</p></sec><sec><title>Conclusion</title><p>Conclusion. Mast cells can potentially play a role in the development of malignant neoplasms of the prostate gland. The number of mast cells increases in pelvic lymph nodes in animals with a created model of metastatic prostate cancer. The obtained direct dependence of the increase in the number of mast cells and the increase in the number of tumor cells with immunoblasts suggests the participation of tissue basophils in the spread of metastases. It can be assumed that infiltration of lymph nodes by mast cells may correlate with a poor prognosis of prostate cancer, since these granulocytes contribute to tumor metastasis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>тучные клетки</kwd><kwd>рак предстательной железы</kwd><kwd>тазовые лимфатические узлы</kwd><kwd>метастазы в регионарные лимфоузлы</kwd><kwd>ангиогенез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mast cells</kwd><kwd>prostate cancer</kwd><kwd>pelvic lymph nodes</kwd><kwd>metastases to regional lymph nodes</kwd><kwd>angiogenesis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Крашенинников А. А., Нюшко К. М., Воробьев Н. В., Мальцагова Х. Р., Алексеев Б. Я., Волченко Н. Н., и др. Аденоплоскоклеточный рак предстательной железы: случай из практики. Южно-Российский онкологический журнал. 2020;1(1):60–68. https://doi.org/10.37748/2687-0533-2020-1-1-5</mixed-citation><mixed-citation xml:lang="en">Krasheninnikov AA, Nyushko KM, Vorobev NV, Maltzagova HR, Alekseev BY, Volchenko NN, et al. Adenosquamous cell cancer of the prostate: a clinical case. South Russian Journal of Cancer. 2020;1(1):60–68. (In Russ). https://doi.org/10.37748/2687-0533-2020-1-1-5</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А. Д., Старинский В. В., Шахзадовой А. О. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России; 2021, 252 с. Доступно по: https://oncology-association.ru/wp-content/uploads/2021/11/zis-2020-elektronnaya-versiya.pdf</mixed-citation><mixed-citation xml:lang="en">Malignant neoplasms in Russia in 2020 (morbidity and mortality). Edited by Kaprin AD, Starinsky VV, Shakhzadova AO. Мoscow: P. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Radiology Research Centre of the Ministry of Health of the Russian Federation, 2021, 252 p. (In Russ). Available at: https://oncology-association.ru/wp-content/uploads/2021/11/zis-2020-elektronnaya-versiya.pdf</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gourdin T. Recent progress in treating advanced prostate cancer. Curr Opin Oncol. 2020 May;32(3):210–215. https://doi.org/10.1097/cco.0000000000000624</mixed-citation><mixed-citation xml:lang="en">Gourdin T. Recent progress in treating advanced prostate cancer. Curr Opin Oncol. 2020 May;32(3):210–215. https://doi.org/10.1097/cco.0000000000000624</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Doat S, Marous M, Rebillard X, Trétarre B, Lamy PJ, Soares P, et al. Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study. Int J Cancer. 2018 Oct 1;143(7):1644–1651. https://doi.org/10.1002/ijc.31565</mixed-citation><mixed-citation xml:lang="en">Doat S, Marous M, Rebillard X, Trétarre B, Lamy PJ, Soares P, et al. Prostatitis, other genitourinary infections and prostate cancer risk: Influence of non-steroidal anti-inflammatory drugs? Results from the EPICAP study. Int J Cancer. 2018 Oct 1;143(7):1644–1651. https://doi.org/10.1002/ijc.31565</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Paolino G, Corsetti P, Moliterni E, Corsetti S, Didona D, Albanesi M, et al. Mast cells and cancer. G Ital Dermatol Venereol. 2019 Dec;154(6):650–668. https://doi.org/10.23736/s0392-0488.17.05818-7</mixed-citation><mixed-citation xml:lang="en">Paolino G, Corsetti P, Moliterni E, Corsetti S, Didona D, Albanesi M, et al. Mast cells and cancer. G Ital Dermatol Venereol. 2019 Dec;154(6):650–668. https://doi.org/10.23736/s0392-0488.17.05818-7</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Sammarco G, Varricchi G, Ferraro V, Ammendola M, De Fazio M, Altomare DF, et al. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. Int J Mol Sci. 2019 Apr 29;20(9):2106. https://doi.org/10.3390/ijms20092106</mixed-citation><mixed-citation xml:lang="en">Sammarco G, Varricchi G, Ferraro V, Ammendola M, De Fazio M, Altomare DF, et al. Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. Int J Mol Sci. 2019 Apr 29;20(9):2106. https://doi.org/10.3390/ijms20092106</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Cristinziano L, Poto R, Criscuolo G, Ferrara AL, Galdiero MR, Modestino L, et al. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. Cells. 2021 Jan 12;10(1):145. https://doi.org/10.3390/cells10010145</mixed-citation><mixed-citation xml:lang="en">Cristinziano L, Poto R, Criscuolo G, Ferrara AL, Galdiero MR, Modestino L, et al. IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors. Cells. 2021 Jan 12;10(1):145. https://doi.org/10.3390/cells10010145</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Aller MA, Arias A, Arias JI, Arias J. Carcinogenesis: the cancer cell-mast cell connection. Inflamm Res. 2019 Feb;68(2):103–116. https://doi.org/10.1007/s00011-018-1201-4</mixed-citation><mixed-citation xml:lang="en">Aller MA, Arias A, Arias JI, Arias J. Carcinogenesis: the cancer cell-mast cell connection. Inflamm Res. 2019 Feb;68(2):103–116. https://doi.org/10.1007/s00011-018-1201-4</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Atiakshin DA, Shishkina VV, Gerasimova OA, Meshkova VY, Samodurova NY, Samoilenko TV, et al. Combined histochemical approach in assessing tryptase expression in the mast cell population. Acta Histochem. 2021 May;123(4):151711. https://doi.org/10.1016/j.acthis.2021.151711</mixed-citation><mixed-citation xml:lang="en">Atiakshin DA, Shishkina VV, Gerasimova OA, Meshkova VY, Samodurova NY, Samoilenko TV, et al. Combined histochemical approach in assessing tryptase expression in the mast cell population. Acta Histochem. 2021 May;123(4):151711. https://doi.org/10.1016/j.acthis.2021.151711</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med. 2012 Aug 16;367(7):647–657. https://doi.org/10.1056/nejmra1112635</mixed-citation><mixed-citation xml:lang="en">Dawson MA, Kouzarides T, Huntly BJ. Targeting epigenetic readers in cancer. N Engl J Med. 2012 Aug 16;367(7):647–657. https://doi.org/10.1056/nejmra1112635</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Tuong ZK, Loudon KW, Berry B, Richoz N, Jones J, Tan X, et al. Resolving the immune landscape of human prostate at a single-cell level in health and cancer. Cell Rep. 2021 Dec 21;37(12):110132. https://doi.org/10.1016/j.celrep.2021.110132</mixed-citation><mixed-citation xml:lang="en">Tuong ZK, Loudon KW, Berry B, Richoz N, Jones J, Tan X, et al. Resolving the immune landscape of human prostate at a single-cell level in health and cancer. Cell Rep. 2021 Dec 21;37(12):110132. https://doi.org/10.1016/j.celrep.2021.110132</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011 Mar;17(3):320–329. https://doi.org/10.1038/nm.2328</mixed-citation><mixed-citation xml:lang="en">Bissell MJ, Hines WC. Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat Med. 2011 Mar;17(3):320–329. https://doi.org/10.1038/nm.2328</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Атякшин Д. А., Костин А. А., Троценко И. Д., Шишкина В. В., Тиманн М., Бухвалов И. Б. Карбоксипептидаза А3 в структуре протеазного фенотипа тучных клеток: цитофизиологические аспекты. Вестник Российского университета дружбы народов. Серия: Медицина. 2022;26(1):9–33. https://doi.org/10.22363/2313-0245-2022-26-1-9-33</mixed-citation><mixed-citation xml:lang="en">Атякшин Д. А., Костин А. А., Троценко И. Д., Шишкина В. В., Тиманн М., Бухвалов И. Б. Карбоксипептидаза А3 в структуре протеазного фенотипа тучных клеток: цитофизиологические аспекты. Вестник Российского университета дружбы народов. Серия: Медицина. 2022;26(1):9–33. (In Russ). https://doi.org/10.22363/2313-0245-2022-26-1-9-33</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Varricchi G, Granata F, Loffredo S, Genovese A, Marone G. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol. 2015 Jul;73(1):144–153. https://doi.org/10.1016/j.jaad.2015.03.041</mixed-citation><mixed-citation xml:lang="en">Varricchi G, Granata F, Loffredo S, Genovese A, Marone G. Angiogenesis and lymphangiogenesis in inflammatory skin disorders. J Am Acad Dermatol. 2015 Jul;73(1):144–153. https://doi.org/10.1016/j.jaad.2015.03.041</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Atiakshin D, Buchwalow I, Tiemann M. Mast cells and collagen fibrillogenesis. Histochem Cell Biol. 2020 Jul;154(1):21–40. https://doi.org/10.1007/s00418-020-01875-9</mixed-citation><mixed-citation xml:lang="en">Atiakshin D, Buchwalow I, Tiemann M. Mast cells and collagen fibrillogenesis. Histochem Cell Biol. 2020 Jul;154(1):21–40. https://doi.org/10.1007/s00418-020-01875-9</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Атякшин Д. А., Клочкова С. В., Шишкина В. В., Никитюк Д. Б., Алексеева Н. Т., Костин А. А. Биогенез и секреторные пути химазы тучных клеток: структурно-функциональные аспекты. Гены и клетки. 2021;16(3):33–43. https://doi.org/10.23868/202110004</mixed-citation><mixed-citation xml:lang="en">Atiakshin DA, Klochkova SV, Shishkina VV, Nikityuk DB, Alekseeva NT, Kostin AA. Biogenesis and secretory pathways of mast cell chymase: structural and functional aspects. Genes and Cells. 2021;16(3):33–43. (In Russ). https://doi.org/10.23868/202110004</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Floroni E, Ceauşu AR, Cosoroabă RM, Niculescu Talpoş IC, Popovici RA, et al. Mast cell density in the primary tumor predicts lymph node metastases in patients with breast cancer. Rom J Morphol Embryol. 2022 Jan-Mar;63(1):129–135. https://doi.org/10.47162/rjme.63.1.13</mixed-citation><mixed-citation xml:lang="en">Floroni E, Ceauşu AR, Cosoroabă RM, Niculescu Talpoş IC, Popovici RA, et al. Mast cell density in the primary tumor predicts lymph node metastases in patients with breast cancer. Rom J Morphol Embryol. 2022 Jan-Mar;63(1):129–135. https://doi.org/10.47162/rjme.63.1.13</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, et al. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. Int J Mol Sci. 2019 Sep 7;20(18):4413. https://doi.org/10.3390/ijms20184413</mixed-citation><mixed-citation xml:lang="en">Ferrari SM, Fallahi P, Galdiero MR, Ruffilli I, Elia G, Ragusa F, et al. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment. Int J Mol Sci. 2019 Sep 7;20(18):4413. https://doi.org/10.3390/ijms20184413</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka T, Ishikawa H. Mast cells and inflammation-associated colorectal carcinogenesis. Semin Immunopathol. 2013 Mar;35(2):245–254. https://doi.org/10.1007/s00281-012-0343-7</mixed-citation><mixed-citation xml:lang="en">Tanaka T, Ishikawa H. Mast cells and inflammation-associated colorectal carcinogenesis. Semin Immunopathol. 2013 Mar;35(2):245–254. https://doi.org/10.1007/s00281-012-0343-7</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ma Z, Yue L, Xu Z, Zeng S, Ma Y, Li Z, et al. The effect of mast cells on the biological characteristics of prostate cancer cells. Cent Eur J Immunol. 2018;43(1):1-8. https://doi.org/10.5114/ceji.2018.74867</mixed-citation><mixed-citation xml:lang="en">Ma Z, Yue L, Xu Z, Zeng S, Ma Y, Li Z, et al. The effect of mast cells on the biological characteristics of prostate cancer cells. Cent Eur J Immunol. 2018;43(1):1–8. https://doi.org/10.5114/ceji.2018.74867</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Pereira BA, Lister NL, Hashimoto K, Teng L, Flandes-Iparraguirre M, Eder A, et al.; Melbourne Urological Research Alliance (MURAL). Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro. Biomaterials. 2019 Mar;197:72–85. https://doi.org/10.1016/j.biomaterials.2018.12.030</mixed-citation><mixed-citation xml:lang="en">Pereira BA, Lister NL, Hashimoto K, Teng L, Flandes-Iparraguirre M, Eder A, et al.; Melbourne Urological Research Alliance (MURAL). Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro. Biomaterials. 2019 Mar;197:72–85. https://doi.org/10.1016/j.biomaterials.2018.12.030</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Johansson A, Rudolfsson S, Hammarsten P, Halin S, Pietras K, Jones J, et al. Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol. 2010 Aug;177(2):1031–1041. https://doi.org/10.2353/ajpath.2010.100070</mixed-citation><mixed-citation xml:lang="en">Johansson A, Rudolfsson S, Hammarsten P, Halin S, Pietras K, Jones J, et al. Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol. 2010 Aug;177(2):1031–1041. https://doi.org/10.2353/ajpath.2010.100070</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Hempel Sullivan H, Heaphy CM, Kulac I, Cuka N, Lu J, Barber JR, et al. High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes. Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):668–675. https://doi.org/10.1158/1055-9965.epi-19-0962</mixed-citation><mixed-citation xml:lang="en">Hempel Sullivan H, Heaphy CM, Kulac I, Cuka N, Lu J, Barber JR, et al. High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer Outcomes. Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):668–675. https://doi.org/10.1158/1055-9965.epi-19-0962</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Pittoni P, Tripodo C, Piconese S, Mauri G, Parenza M, Rigoni A, et al. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res. 2011 Sep 15;71(18):5987–5997. https://doi.org/10.1158/0008-5472.can-11-1637</mixed-citation><mixed-citation xml:lang="en">Pittoni P, Tripodo C, Piconese S, Mauri G, Parenza M, Rigoni A, et al. Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res. 2011 Sep 15;71(18):5987–5997. https://doi.org/10.1158/0008-5472.can-11-1637</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ammendola M, Patruno R, Sacco R, Marech I, Sammarco G, Zuccalà V, Luposella M, Zizzo N, Gadaleta C, Porcelli M, Gadaleta CD, Ribatti D, Ranieri G. Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery. Expert Opin Ther Targets. 2016;20(5):533–540. https://doi.org/10.1517/14728222.2016.1158811</mixed-citation><mixed-citation xml:lang="en">Ammendola M, Patruno R, Sacco R, Marech I, Sammarco G, Zuccalà V, Luposella M, Zizzo N, Gadaleta C, Porcelli M, Gadaleta CD, Ribatti D, Ranieri G. Mast cells positive to tryptase and tumour-associated macrophages correlate with angiogenesis in locally advanced colorectal cancer patients undergone to surgery. Expert Opin Ther Targets. 2016;20(5):533–540. https://doi.org/10.1517/14728222.2016.1158811</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
